About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Therapeutic Area
Nicotine Replacement Therapy Market Expected to Grow at 7.4% by 2032
Nicotine Replacement Therapy Market By Product (Smoking Cessation Aids, Vaping System), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Stores) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032
31 Jul 2023
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Nicotine Replacement Therapy Market
2.2. Global Nicotine Replacement Therapy Market, By Product, 2023 (US$ Million)
2.3. Global Nicotine Replacement Therapy Market, By Distribution Channel, 2023 (US$ Million)
2.4. Global Nicotine Replacement Therapy Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Nicotine Replacement Therapy Market: Competitive Analysis
3.1. Market Positioning of Key Nicotine Replacement Therapy Market Vendors
3.2. Strategies Adopted by Nicotine Replacement Therapy Market Vendors
3.3. Key Industry Strategies
4. Nicotine Replacement Therapy Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Nicotine Replacement Therapy Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Smoking Cessation Aids
5.3.1.1. Nicotine Inhalers
5.3.1.2. Nicotine Gums
5.3.1.3. Nicotine Lozenges
5.3.1.4. Nicotine Patches
5.3.1.5. Others (nicotine tablets, nicotine spray, etc.)
5.3.2. Vaping System
5.3.2.1. E-cigarettes
5.3.2.2. Heat-not-burn Tobacco Products
6. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Retail Pharmacies
6.3.2. Hospital Pharmacies
6.3.3. Online Stores
7. North America Nicotine Replacement Therapy Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
7.3. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
7.4.Nicotine Replacement Therapy Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
7.4.1.1.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
7.4.1.2.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
7.4.1.3.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
8. UK and European Union Nicotine Replacement Therapy Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
8.3. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.Nicotine Replacement Therapy Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
8.4.1.1.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
8.4.1.2.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
8.4.1.3.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
8.4.1.4.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
8.4.1.5.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
8.4.1.6.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
9. Asia Pacific Nicotine Replacement Therapy Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
9.3. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.Nicotine Replacement Therapy Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
9.4.1.1.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
9.4.1.2.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
9.4.1.3.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
9.4.1.4.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
9.4.1.5.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
9.4.1.6.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
10. Latin America Nicotine Replacement Therapy Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
10.3. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
10.4.Nicotine Replacement Therapy Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
10.4.1.1.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
10.4.1.2.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
10.4.1.3.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
11. Middle East and Africa Nicotine Replacement Therapy Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
11.3. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
11.4.Nicotine Replacement Therapy Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
11.4.1.1.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
11.4.1.2.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Nicotine Replacement Therapy Market: By Product, 2022-2032, USD (Million)
11.4.1.3.2. Nicotine Replacement Therapy Market: By Distribution Channel, 2022-2032, USD (Million)
12. Company Profile
12.1. Haleon Group of Companies
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Perrigo Company plc
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. SAABI NZ PTY Limited
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Pfizer, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. PL Developments
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Philip Morris International, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Cipla Limited
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. JUUL Labs, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. JT International SA
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Imperial Brands plc
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Pierre Fabre S.A.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Sparsha Pharma International Pvt. Ltd.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Rubicon Research Pvt. Ltd.
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Lucy Goods
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. McNeil AB (Johnson & Johnson)
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. BAT plc.
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives
12.17. Fontem Holdings 4 B.V.
12.17.1. Company Overview
12.17.2. Financial Performance
12.17.3. Product Portfolio
12.17.4. Strategic Initiatives
12.18. Other Notable Players
12.18.1. Company Overview
12.18.2. Financial Performance
12.18.3. Product Portfolio
12.18.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4500
Multi User license
$6500
Corporate license
$9000
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234